Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PUT
LPL Financial
LPLA
$28.5B
| $38.4M | 0.01% |
117,500
-17,800
| -13% | -$5.26M |
|
1502
PUT
Cardinal Health
CAH
$53.4B
| $38.2M | 0.01% |
323,100
+195,700
| +154% | +$22.8M |
|
1503
GE HealthCare
GEHC
$33.8B
| $38.2M | 0.01% |
488,376
-3,058,206
| -86% | -$260M |
|
1504
Expro Ltd
XPRO
$2.05B
| $38.1M | 0.01% |
3,057,920
-129,609
| -4% | -$1.81M |
|
1505
CALL
Matador Resources
MTDR
$7.22B
| $38.1M | 0.01% |
677,600
+251,200
| +59% | +$13.8M |
|
1506
CALL
Paychex
PAYX
$44.3B
| $38.1M | 0.01% |
271,500
-236,900
| -47% | -$33.6M |
|
1507
Ocular Therapeutix
OCUL
$2.43B
| $38.1M | 0.01% |
4,456,810
+196,972
| +5% | +$1.92M |
|
1508
Canadian Natural Resources
CNQ
$106B
| $37.9M | 0.01% |
1,229,194
-302,824
| -20% | -$10.2M |
|
1509
PUT
American Electric Power
AEP
$65.8B
| $37.8M | 0.01% |
410,200
-61,100
| -13% | -$5.91M |
|
|
OKLO
1510
CALL
Oklo
OKLO
$7.83B
| $37.8M | 0.01% |
1,781,100
+1,536,300
| +628% | +$29.8M |
|
1511
Ciena
CIEN
$56B
| $37.7M | 0.01% |
444,616
-147,513
| -25% | -$10.6M |
|
|
AKRO
1512
DELISTED
Akero Therapeutics
AKRO
| $37.7M | 0.01% |
1,354,893
+1,204,992
| +804% | +$36.5M |
|
1513
CALL
Skyworks Solutions
SWKS
$10.1B
| $37.7M | 0.01% |
424,900
+39,600
| +10% | +$3.6M |
|
1514
HF Sinclair
DINO
$17.3B
| $37.5M | 0.01% |
1,070,786
+910,641
| +569% | +$37.2M |
|
1515
CALL
NIO
NIO
$11.6B
| $37.5M | 0.01% |
8,605,000
+179,500
| +2% | +$913K |
|
1516
Disc Medicine
IRON
$3.06B
| $37.5M | 0.01% |
591,271
+180,247
| +44% | +$10.4M |
|
1517
PUT
Parker-Hannifin
PH
$126B
| $37.5M | 0.01% |
58,900
+12,500
| +27% | +$8.28M |
|
1518
Vanguard FTSE Europe ETF
VGK
$31.2B
| $37.4M | 0.01% |
589,785
+574,063
| +3,651% | +$38.3M |
|
1519
BP
BP
$115B
| $37.4M | 0.01% |
1,265,463
-41,359
| -3% | -$1.24M |
|
1520
CALL
Rigetti Computing
RGTI
$5.98B
| $37.3M | 0.01% |
2,443,800
+2,304,200
| +1,651% | +$8.6M |
|
1521
PUT
Yum! Brands
YUM
$41.8B
| $37.3M | 0.01% |
277,700
-361,600
| -57% | -$48.9M |
|
1522
CALL
Targa Resources
TRGP
$64.1B
| $37.2M | 0.01% |
208,600
+2,800
| +1% | +$502K |
|
1523
PUT
British American Tobacco
BTI
$121B
| $37.1M | 0.01% |
1,021,600
+516,200
| +102% | +$18.6M |
|
1524
FTAI Aviation
FTAI
$21.5B
| $37M | 0.01% |
257,033
+26,491
| +11% | +$3.91M |
|
|
ETNB
1525
DELISTED
89bio
ETNB
| $37M | 0.01% |
4,729,852
+2,173,125
| +85% | +$17.9M |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.